caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1609054659

Svetlana MeierMD

PRACTICEIDAHO ARTHRITIS & OSTEOPOROSIS CENTER PCSee all providers at this practice →
RheumatologyMeridian, IDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Svetlana Meier's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Seattle, WA
81205
James Hill
Diagnostic Radiology · Boise, ID
23100
David Mcnaul
Diagnostic Radiology · Columbia, MO
1526
Steven Marx
Diagnostic Radiology · Boise, ID
1327
MOORE, MONTE1138
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
4,691
Unique beneficiaries
—
Total services
234,532
Distinct HCPCS
45
Medicare payment
$2.3M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 21 Rheumatology providers in ID — top quintile (cohort median 646).
PRESCRIBING · PART D · 2024
Total Rx claims
1,894
Beneficiaries
—
Total drug cost
$803K
Distinct drugs
26
Brand share
26.2%
Top prescribed drugs
Methotrexate Sodium362 claims
Hydroxychloroquine Sulfate326 claims
Prednisone293 claims
Allopurinol168 claims
Leflunomide98 claims
QUALITY · MIPS · 2024
Final MIPS score
91.0
Quality
100.0
Cost
70.1
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.67%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.